Listing & Compliance Notices

SES AI Corp received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“March 7, 2025, SES AI Corporation (the “Company”) was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s Class A common stock was less than $1.00 over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the Company’s Class A common stock from the NYSE. The Company intends to notify the NYSE of its intent to regain compliance with the NYSE continued listing standard. The Company can regain compliance at any time within”

Thunder Power Holdings, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5450(b)(2)(A)).

“March 7, 2025, Thunder Power Holdings, Inc., a Delaware corporation (the “Company”) received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not regained compliance with Nasdaq Listing Rules 5450(a)(1), which requires the Company’s listed securities to maintain a minimum bid price of $1.00 per share (the “Bid Price Rule”) and 5450(b)(2)(A), which requires the Company to maintain a minimum Market Value of Listed Securities (“MVLS”) of $50,000,000 (the “MVLS Rule”). Accordingly, the Nasdaq Staff has de”

American Bitcoin Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5505(b)(1)).

“March 5, 2025, the Company received a staff delist determination letter from the Nasdaq Listing Qualifications Department, as a result of its failure to regain compliance with the Minimum Bid Price Rule. The Company was not automatically eligible for a second 180-day compliance period because it did not meet the initial listing requirement of $5.0 million of stockholders’ equity, or other listing alternatives, for Nasdaq Capital Market as set forth under Nasdaq Listing Rule 5505(b)(1). The Company intends to timely request a hearing before a Nasdaq Hearings Panel (the “Panel”). This hearing re”

GRI Bio, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“March 10, 2025, GRI Bio, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the bid price deficiency under Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule"), which the Company previously reported on in its Current Reports on Form 8-K filed on September 10, 2024 and Form 8-K/A filed on September 11, 2024, has been cured, and that the Company is now in compliance with the Minimum Bid Price Rule.”

FGI Industries Ltd. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“September 6, 2024 that the closing bid price for our common stock had been below $1.00 per share for the previous 30 consecutive business days, and that we were therefore not in compliance with the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). Pursuant to the original notice, the Company had a 180-day period in which to regain compliance. Neither the original notice nor the extension has any immediate effect on the listing or trading of our common stock on The Nasdaq Capital Market. We remain subject”

FGI Industries Ltd. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“er 6, 2024 that the closing bid price for our common stock had been below $1.00 per share for the previous 30 consecutive business days, and that we were therefore not in compliance with the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). Pursuant to the original notice, the Company had a 180-day period in which to regain compliance. Neither the original notice nor the extension has any immediate effect on the listing or trading of our common stock on The Nasdaq Capital Market. We remain subject to the”

Global Star Acquisition Inc. received a nasdaq delisting notice notice regarding other (rules 5450(a)(2), 5450(b)(2)(A), 5450(b)(2)(C), 5101, IM-5101-1).

“March 7, 2025, the Staff notified the Company that it failed multiple continued listing requirements by significant margins. Additionally, Staff notified the Company that pursuant to its discretionary authority under Listing Rules 5101,1 and IM-5101-12, Nasdaq determined to suspend trading in the Company’s securities in order to maintain the quality of and public confidence in the Nasdaq market, to prevent fraudulent and manipulative acts and practices, to promote just and equitable principles of trade, and to protect investors and the public interest. As previously disclosed, on December 18”

PIXELWORKS, INC received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1), 5550(a)(2)).

“March 7, 2025, Nasdaq notified the Company that it had approved the Company’s application to transfer its listing to the Nasdaq Capital Market. The Company’s securities will be transferred to the Nasdaq Capital Market at the opening of business on March 11, 2025. Nasdaq also approved a 180-day extension, or until September 8, 2025, to regain compliance with the Bid Price Requirement in accordance with Nasdaq Listing Rule 5550(a)(2). To regain compliance, the Company’s common stock must maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days at any”

Perfect Moment Ltd. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii)).

“March 4, 2025, the Company received a notification (the “Notification”) from the NYSE American stating that the Company is not in compliance with the $2 million stockholders’ equity requirement of Section 1003(a)(i) of the Company Guide. In its Quarterly Report on Form 10-Q for the period ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 14, 2025, the Company reported stockholders’ equity of $907,000 and losses from continuing operations and/or net losses in three out of its four most recent fiscal years ended March 31, 2024. Pursuant to th”

Investcorp AI Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

“March 4, 2025, Investcorp AI Acquisition Corp., a Cayman Islands exempted company (the “ Company ”) received a notification letter (the “ Notification Letter ”) from the Listing Qualifications Department (the “ Staff ”) of the Nasdaq Stock Market LLC (“ Nasdaq ”) indicating the Company’s failure to satisfy a continued listing standard from Nasdaq under Listing Rule 5620(a). The Notification Letter indicated that the Company failed to hold an annual meeting of stockholders within the required twelve-month period from the end of the Company’s fiscal year. The Notification Letter is only a notifi”

Aquaron Acquisition Corp. received a nasdaq delisting notice notice regarding shareholders (rules 5550(a)(3), 5505).

“March 6, 2025, the Company received a determination letter (the “ Delisting Notification ”) from the Nasdaq stating that the Panel has determined to delist the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”) from the Nasdaq Capital Market, and Nasdaq will accordingly suspend trading in the Company’s Common Stock, effective at the opening of trading on March 7, 2025, because the Company has not demonstrated compliance with the Rule. Pursuant to the Delisting Notification, the Company has a period of 15 days from the date of the Delisting Notification to submit a writt”

CUMULUS MEDIA INC received a nasdaq deficiency notice notice regarding stockholders equity (rules 5450(b)(1)(A)).

“March 6, 2025, Cumulus Media Inc. (the “Company”) received a notification from the Listing Qualifications Department of The NASDAQ Stock Market LLC (“NASDAQ”) indicating that, based on the Company’s stockholders’ equity of $6,951,000 as of December 31, 2024, as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, the Company is not in compliance with the minimum stockholders’ equity requirement for continued listing on the NASDAQ Global Market under NASDAQ Listing Rule 5450(b)(1)(A), which requires companies to maintain stockholders’ equity of at least $10”

CUTERA INC received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).

“March 6, 2025, Cutera, Inc. (the “ Company ”) was notified by the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) that Nasdaq had determined to delist the Company’s common stock, par value $0.001 per share (the “ Common Stock ”). Nasdaq reached its decision that the Company is no longer suitable for listing pursuant to Nasdaq Listing Rules 5101, 5110(b), and IM‐5101-1 as a result of the Company’s commencement of voluntary proceedings under Chapter 11 of the United States Bankruptcy Code (“ Chapter 11 ”) on March 5, 2025. The Company does not intend to appeal this”

KUSTOM ENTERTAINMENT, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iii)).

“March 6, 2025, the Company received notice (the “March 6 Letter”) from the Staff that the Staff had determined that as of March 5, 2025, the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days triggering application of Listing Rule 5810(c)(3)(A)(iii) which states in part: if during any compliance period specified in Rule 5810(c)(3)(A), a company’s security has a closing bid price of $0.10 or less for ten consecutive trading days, the Listing Qualifications Department shall issue a Staff Delisting Determination under Rule 5810 with respect to that secu”

ADIAL PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“March 5, 2025, Adial Pharmaceuticals, Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the preceding 30 consecutive business days (January 17, 2025 through March 4, 2025), the Company’s common stock did not maintain a minimum closing bid price of $1.00 (“Minimum Bid Price Requirement”) per share as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade on The Na”

Envirotech Vehicles, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“March 6, 2025, Envirotech Vehicles, Inc., a Delaware corporation (the “Company”), received a letter (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business days from January 21, 2025 to March 5, 2025, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A)”

Sphere 3D Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“March 6, 2025, Sphere 3D Corp. ("the Company") received a notice from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") stating that the bid price of the Company's common shares for the last 30 consecutive trading days had closed below the minimum $1.00 per share required for continued listing under Listing Rule 5550(a)(2) (the "Listing Rule"). The Company has a period of 180 calendar days, or until September 2, 2025, to regain compliance with the Listing Rule. The notice from Nasdaq has no immediate effect on the listing or trading of the Company's common”

GridAI Technologies Corp. received a nasdaq noncompliance notice notice regarding shareholders (rules 5620(a)).

“January 7, 2025, a formal letter from Nasdaq notifying the Company that it did not comply with Nsadaq Listing Rule 5620(a) (the “Annual Meeting Rule”), which requires that it hold an annual meeting of shareholders within twelve months of the end of the Company’s fiscal year end. On February 21, 2025, the Company submitted to the Staff a plan of compliance which described the circumstances under which it became noncompliant with the Annual Meeting Rule and the Company’s plan with which it will regain compliance. The Staff in its letter dated March 3, 2025 determined to grant the Company an exte”

GridAI Technologies Corp. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).

“s days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided 180 days, or until March 5, 2025, to regain compliance with the Minimum Bid Price Requirement. On March 6, 2025, the Company received a letter from Nasdaq (the “Extension Notice”) advising that the Company has been granted a 180-day extension, or until Septemb”

Sports Entertainment Gaming Global Corp received a nasdaq compliance regained notice regarding market value (rules 5450(a)(1), 5450(b)(1)(c)).

“March 6, 2025 Lottery.com received a letter from Nasdaq determining that as a result of the Company’s common stock closing at a bid price at or above $1.00 for twenty consecutive business days and its MVPHS being above $5,000,000 or more during the same period, the Company had regained compliance with both the Bid Price Listing Rule and the MVPHS Listing Rule. Nasdaq has closed both matters. Forward Looking Statements This Current Report on Form 8-K (the “Form 8-K”) contains statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933”

Sports Entertainment Gaming Global Corp received a nasdaq compliance regained notice regarding minimum bid price (rules 5450(a)(1), 5450(b)(1)(c)).

“March 6, 2025 Lottery.com received a letter from Nasdaq determining that as a result of the Company’s common stock closing at a bid price at or above $1.00 for twenty consecutive business days and its MVPHS being above $5,000,000 or more during the same period, the Company had regained compliance with both the Bid Price Listing Rule and the MVPHS Listing Rule. Nasdaq has closed both matters. Forward Looking Statements This Current Report on Form 8-K (the “Form 8-K”) contains statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933”

Motorsport Games Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“March 3, 2025, the Nasdaq Stock Market LLC (“Nasdaq”) notified Motorsport Games Inc. (the “Company”) that, based on Nasdaq’s review of the Company and the materials submitted by the Company to Nasdaq, Nasdaq’s staff has determined to grant the Company an extension to regain compliance with Nasdaq’s minimum $2,500,000 stockholders’ equity requirement set forth in Listing Rule 5550(b)(1) (the “NCM Equity Rule”), until April 14, 2025, subject to the Company’s regaining and evidencing compliance with the NCM Equity Rule by such date. The deficiency with respect to the Company’s compliance with the”

Pinstripes Holdings, Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).

“March 5, 2025, the NYSE notified the Company and publicly disclosed that it has determined to commence proceedings to delist the Company’s Common Stock, as a result of the Company’s non-compliance with Rule 802.01B of the NYSE Listed Company Manual that requires listed companies to maintain an average global market capitalization of at least $15 million over a period of 30 consecutive trading days. Trading of the Common Stock on the NYSE was suspended after market close on March 5, 2025. The NYSE will apply to the Securities and Exchange Commission (the “SEC”) to delist the Common Stock upon c”

Pinstripes Holdings, Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).

“March 5, 2025, the NYSE notified the Company and publicly disclosed that it has determined to commence proceedings to delist the Company’s Common Stock, as a result of the Company’s non-compliance with Rule 802.01B of the NYSE Listed Company Manual that requires listed companies to maintain an average global market capitalization of at least $15 million over a period of 30 consecutive trading days. Trading of the Common Stock on the NYSE was suspended after market close on March 5, 2025. The NYSE will apply to the Securities and Exchange Commission (the “SEC”) to delist the Common Stock upon c”

DIH HOLDING US, INC. received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(2)(A)).

“March 5, 2025, DIH Holding US, Inc. (the “ Company ”), received a letter (the “ MVLS Notice”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that for the last 30 consecutive business days prior to the date of the MVLS Notice, the Company’s Minimum Value of Listed Securities (“ MVLS ”) was less than $50.0 million, which does not meet the requirement for continued listing on The Nasdaq Global Market, as required by Nasdaq Listing Rule 5450(b)(2)(A)) (the “ MVLS Rule ”). In accordance with Nasdaq Listing Rule 5810(c)(3)”

iCoreConnect Inc. received a nasdaq deficiency notice notice regarding other (rules 5605(b)(1), 5605(c)(2)(A)).

“(the “Company”) notified the Nasdaq Stock Market LLC (“Nasdaq”) that the Company will not be in compliance with the majority independent director requirement under Nasdaq Listing Rule 5605(b)(1) and the audit committee requirement under Nasdaq Listing Rule 5605(c)(2)(A) as of March 5, 2025, solely due to a vacancy on the Company’s Board of Directors (the “Board”) and audit committee (the “Audit Committee”) of the Board resulting from Yvonne Hyland’s resignation from the Board as disclosed in”

New ERA Energy & Digital, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

“March 4, 2025, New Era Helium Inc. (the “Company”) received a letter from Nasdaq (the “Notice”) which notified the Company that, for 30 consecutive business days, the Company’s market value of listed securities (“MVLS”) closed below the $50,000,000 MVLS threshold required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has 180 calendar days, or until September 2, 2025 (the “MVLS Compliance Period”), to regain compliance with the MVLS Rule. The Notice notes that, to reg”

NextTrip, Inc. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

“March 3, 2025, the Company also received a notification letter from the Staff of Nasdaq notifying the Company that, based on the Current Report on Form 8-K filed by the Company with the Commission on February 18, 2024, the Staff has determined the Company has regained compliance with the minimum stockholders’ equity requirements set forth in Nasdaq Listing Rule 5550(b)(1) (the “Equity Rule”). However, if the Company fails to evidence compliance with the Equity Rule upon filing its next periodic report, the Company may be subject to delisting. At that time, Staff will provide written notificati”

NextTrip, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

“March 3, 2025, the Company also received a notification letter from the Staff of Nasdaq notifying the Company that, based on the Current Report on Form 8-K filed by the Company with the Commission on February 18, 2024, the Staff has determined the Company has regained compliance with the minimum stockholders’ equity requirements set forth in Nasdaq Listing Rule 5550(b)(1) (the “Equity Rule”). However, if the Company fails to evidence compliance with the Equity Rule upon filing its next periodic report, the Company may be subject to delisting. At that time, Staff will provide written notificati”

ARCBEST CORP /DE/ received a nasdaq compliance regained notice regarding audit committee (rules 5605(c)(2)(A), 5605(a)(2)(F)).

“March 3, 2025, ArcBest Corporation (the “Company”) received a notice from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) after the Company discovered and self-reported that it did not fully comply with the audit committee composition requirements set forth in Nasdaq Listing Rule 5605(c)(2)(A). The non-compliance was a result of Fredrik J. Eliasson, a member of the Audit Committee, not qualifying as independent pursuant to Nasdaq Listing Rule 5605(a)(2)(F) due to his brother-in-law serving as a partner of the Company’s outside auditor for”

HCW Biologics Inc. received a nasdaq hearing update notice regarding minimum bid price (rules 5810(c)(3)(A)).

“ously disclosed, on February 5, 2025, the Company received written notice from the Staff that its securities were subject to delisting from Nasdaq since the Company did not regain compliance with the requirement to maintain a minimum bid price of $1 per share, in accordance with Nasdaq Listing Rule 5810(c)(3)(A) (“Bid Price Rule”) and the requirement to maintain the minimum $15,000,000 market value of publicly held securities (“MVPHS”) threshold required for continued listing on The Nasdaq Global Market ® under Nasdaq Listing Rule 5450(b)(2)C) (the “MVPHS Rule”). On March 3, 2025, the Panel gr”

HCW Biologics Inc. received a nasdaq hearing update notice regarding market value (rules 5450(b)(3)(A), 5450(b)(2)(C)).

“arket LLC (“Nasdaq” or the “Exchange”) that its securities were subject to delisting from Nasdaq since the Company did not regain compliance with the $50,000,000 market value of listed securities (“MVLS”) threshold required for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(3)(A) (the “MVLS Rule”). The Company made a timely request for a hearing before the Nasdaq Hearings Panel (the “Panel”) and was granted a hearing date on February 13, 2025. As previously disclosed, on February 5, 2025, the Company received written notice from the Staff that its securities we”

GRAPHJET TECHNOLOGY received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

“March 5, 2025, the Company received a second notification letter (the “Second Notice”) from Nasdaq which notified the Company that, for the 30 consecutive business days, the Company’s market value of listed securities (“MVLS”) closed below the $50,000,000 MVLS threshold required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has 180 calendar days, or until September 1, 2025 (the “MVLS Compliance Period”), to regain compliance with the MVLS Rule. The Second Notice note”

GRAPHJET TECHNOLOGY received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“th the Securities and Exchange Commission (the “SEC”) and (ii) the Company’s delay in filing its Annual Report on Form 10-Q for the period ended December 31, 2024 (the “Second Delinquent Filing”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The First Notice states that the Company has 60 calendar days, or until April 29, 2025, to submit a plan to regain compliance with the Listing Rule with respect to the delinquent reports. If Nasdaq accepts the Company’s plan to regain compliance, then Nasdaq may gran”

Zomedica Corp. received a nyse_american delisting notice notice regarding minimum bid price (rules 1003(f)(v)).

“March 4, 2025, Zomedica Corp. (the “ Company ”) was notified by The NYSE American LLC (“ NYSE American ”) that as a result of the Company’s previously disclosed noncompliance with Section 1003(f)(v) of the NYSE American Company Guide whereby the Company’s common shares were trading for a substantial period of time at a low price per share, NYSE American has suspended trading in the Company’s common shares as of March 4, 2025. NYSE American further indicated that it will apply to the Securities and Exchange Commission (the “ SEC ”) to delist the Company’s common shares upon completion of all ap”

Longevity Health Holdings, Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“March 4, 2025, the Company received written notice from the Department notifying the Company that it had failed to regain compliance with the MVLS Requirement by the Compliance Date. As such, unless the Company requests an appeal of Nasdaq’s determination to delist the Company’s securities from the Nasdaq Capital Market by March 11, 2025, trading of the Company’s common stock will be suspended at the opening of business on March 13, 2025, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registra”

Hyperscale Data, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).

“December 18, 2024, Hyperscale Date, Inc. (the “ Company ”) was notified by the NYSE American, LLC (the “ Exchange ”) that due to the Company’s disclosure in its Form 10-Q filed for the fiscal period ended September 30, 2024, which reported stockholders’ equity of approximately $2.2 million, it no longer meets the requirement that it must have no less than $6 million or more in stockholders’ equity pursuant to the listing standard set forth under Section 1003(a)(ii) and (iii) of the NYSE American Company Guide (the “ Listing Standards ”) because the Company has reported losses from continuing o”

Crown Electrokinetics Corp. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“March 3, 2025, the Company received a letter from the Panel stating that the Panel had determined to deny the Company’s request to continue listing on Nasdaq and that trading in the Company’s common stock will be suspended at the open of trading on March 5, 2025. The Company intends to submit a request for reconsideration to the Panel and to otherwise appeal the determination to the Nasdaq Listing and Hearing Review Council, as necessary. While the Company pursues those processes, trading in the Company’s common stock will be suspended on Nasdaq. As a result of the suspension in trading and ex”

CHARLES & COLVARD LTD received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“February 25, 2025, Charles & Colvard, Ltd. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that because the Company had not yet filed its Form 10-Q for the quarter ended December 31, 2024 (the “Q2 FY2025 Form 10-Q”), and because the Company remains delinquent in filing its Form 10-Q for the quarter ended September 30, 2024 (the “Q1 FY2025 Form 10-Q”) and its Form 10-K for the fiscal year ended June 30, 2024 (the “Form 10-K”), the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c”

Healthcare Triangle, Inc. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

“February 28, 2025, the Company received net proceeds of $13.68 million from its $15.2 million private placement of units consisting of common stock or prefunded warrants and series A warrants and series B warrants (the “Private Offering”). As of February 28, 2025, the Company believes it is in compliance with the Minimum Equity Requirement as a result of receiving approximately $13.68 million in net proceeds from the Private Offering, after considering anticipated net losses through February 28, 2025. Nasdaq will continue to monitor the Company’s ongoing compliance with the Minimum Equity Requ”

Envoy Medical, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“February 25, 2025, Envoy Medical, Inc. (the “Company”) received a deficiency notification letter (the “Notification Letter”) from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(2) (the “Rule”) because the market value of the Company’s listed securities did not meet the minimum of $35,000,000 for the period for 31 consecutive business days between January 7, 2025 and February 24, 2025. Pursuant to Nasdaq’s Listing Rules, the Company will return to compliance if the market value of its listed securities exceeds $35,000,000 for t”

USBC, Inc. received a nyse_american compliance regained notice regarding other (rules 1003(f)(v)).

“February 27, 2025, Know Labs, Inc., a Nevada corporation (the “Company”) received a notification from NYSE American LLC (“NYSE American”) informing the Company that it has resolved the continued listing deficiency with respect to low selling price as described in Section 1003(f)(v) of the NYSE American Company Guide (“Company Guide”). As a result, the staff of NYSE Regulation has withdrawn its delisting determination and will be lifting the trading suspension of the Company’s common stock on NYSE American. The common stock will commence trading on NYSE American on Wednesday, March 5, 2025 unde”

Mersana Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“February 25, 2025, Mersana Therapeutics, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1) because the Company has not maintained a minimum closing bid price of the Company’s common stock of at least $1.00 per share for the last 30 consecutive business days (the “Minimum Bid Price Requirement”). The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. In accordance with Nasda”

BOLLINGER INNOVATIONS, INC. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“February 25, 2025, Mullen Automotive Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Staff (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that for the last 30 consecutive business days prior to the date of the Notice, the Company’s Market Value of Listed Securities (“ MVLS ”) was less than the $35.0 million minimum required for continued listing on The Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(b)(2) (the “ MVLS Listing Rule ”). Additionally, as of the date of the Notice, the Company did no”

Beeline Holdings, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“February 26, 2025, Eastside Distilling, Inc., d/b/a Beeline Holdings (the “Company”) received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company is eligible for an additional 180 calendar day period, or until August 25, 2025, to regain compliance with the Nasdaq Listing Rule 5550(a)(2) (the “Rule”). As of the date of the letter, the Company remained noncompliant with the Rule by failing to maintain a minimum bid price for its common stock of at least $1.00 per share for 30 consecutive business days. Prior to the recent letter, the Company had received t”

Spero Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“otifying the Company that, for the preceding 30 consecutive trading days, the closing bid price of its common stock was below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). At this current time, this Notice has no effect on the listing of the Company’s common stock, which continues to trade on the Nasdaq Global Select Market (“Nasdaq GS”) under the symbol “SPRO”.”

urban-gro, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“0 consecutive business days, the bid price for the Company’s common stock, par value $0.001 per share (the “Common Stock”) had closed at a price of below $1.00 per share, which is the minimum closing price required to maintain continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “ Minimum Bid Requirement ”). The notice has no immediate effect on the listing of the Common Stock on Nasdaq. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days to regain compliance with the Minimum Bid Requirement. To regain compliance with the”

urban-gro, Inc. received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1)).

“0 consecutive business days, the bid price for the Company’s common stock, par value $0.001 per share (the “Common Stock”) had closed at a price of below $1.00 per share, which is the minimum closing price required to maintain continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “ Minimum Bid Requirement ”). The notice has no immediate effect on the listing of the Common Stock on Nasdaq. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days to regain compliance with the Minimum Bid Requirement. To regain compliance with the”

Generation Bio Co. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“February 24, 2025, Generation Bio Co. (the “Company”) received written notification (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Select Market, pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). The Notice has no immediate effect on the listing of the Company’s com”

ZeroStack Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“February 25, 2025, Flora Growth Corp. a corporation organized under the laws of the Province of Ontario ( the " Company ") received a notice (the " Notice ") from the Listing Qualifications Department (the " Staff ") of the Nasdaq Stock Market (" Nasdaq ") stating that for 30 consecutive business days the Company's common shares (the " Common Shares ") did not maintain a minimum closing bid price of $1.00 per share (" Minimum Bid Price Requirement ") as required for continued listing under Listing Rule 5550(a)(2). The Notice has no immediate effect on the listing of the Common Shares. In acco”